Article Details

ArriVent BioPharma Enters Exclusive License with Lepu - GlobeNewswire

Retrieved on: 2025-01-22 00:02:46

Tags for this article:

Click the tags to see associated articles and topics

ArriVent BioPharma Enters Exclusive License with Lepu - GlobeNewswire. View article details on hiswai:

Excerpt

ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo